{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T03:18:03Z","timestamp":1778728683541,"version":"3.51.4"},"reference-count":52,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2012,7,4]],"date-time":"2012-07-04T00:00:00Z","timestamp":1341360000000},"content-version":"vor","delay-in-days":6363,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[1995,2]]},"abstract":"<jats:p>1. Fluvoxamine and seven other selective serotonin reuptake inhibitors (SRRI) were tested for their ability to inhibit a number of human cytochrome P450 isoforms (CYPs). 2. None of the drugs showed potent inhibition of CYP2A6 (coumarin 7\u2010hydroxylase) or CYP2E1 (chlorzoxazone 6\u2010hydroxylase), while norfluoxetine was the only potent inhibitor of CYP3A having IC50 values of 11 microM and 19 microM for testosterone 6 beta\u2010hydroxylase and cortisol 6 beta\u2010hydroxylase, respectively. 3. Norfluoxetine, sertraline and fluvoxamine inhibited CYP1A1 (7\u2010 ethoxyresorufin O\u2010deethylase) in microsomes from human placenta (IC50 values 29 microM, 35 microM and 80 microM, respectively). Fluvoxamine was a potent inhibitor of CYP1A2\u2010mediated 7\u2010ethoxyresorufin O\u2010 deethylase activity (IC50 = 0.3 microM) in human liver. 4. In microsomes from three human livers fluvoxamine potently inhibited all pathways of theophylline biotransformation, the apparent inhibitor constant, Ki, was 0.07\u20100.13 microM, 0.05\u20100.10 microM and 0.16\u20100.29 microM for inhibition of 1\u2010methylxanthine, 3\u2010methylxanthine and 1,3\u2010 dimethyluric acid formation, respectively. Seven other SSRIs showed either weak or no inhibition of theophylline metabolism. 5. Ethanol inhibited the formation of 1,3\u2010dimethyluric acid with K(i) value of 300 microM, a value which is consistent with inhibition of CYP2E1. Ethanol and fluvoxamine both inhibited 8\u2010hydroxylation by about 45% and, in combination, the compounds decreased the formation of 1,3\u2010dimethyluric acid by 90%, indicating that CYP1A2 and CYP2E1 are equally important isoforms for the 8\u2010hydroxylation of theophylline. 6. It is concluded that pharmacokinetic interaction between fluvoxamine and theophylline is due to potent inhibition of CYP1A2.<\/jats:p>","DOI":"10.1111\/j.1365-2125.1995.tb04422.x","type":"journal-article","created":{"date-parts":[[2012,7,5]],"date-time":"2012-07-05T04:34:13Z","timestamp":1341462853000},"page":"151-159","source":"Crossref","is-referenced-by-count":107,"title":["Selective serotonin reuptake inhibitors and theophylline metabolism in human liver microsomes: potent inhibition by fluvoxamine."],"prefix":"10.1111","volume":"39","author":[{"given":"BB","family":"Rasmussen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Maenpaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O","family":"Pelkonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Loft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HE","family":"Poulsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Lykkesfeldt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Brosen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,7,4]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1992.tb04133.x"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1992.tb04134.x"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1993.43"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(93)90272-X"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.20.7696"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1988.tb03393.x"},{"key":"e_1_2_1_8_2","first-page":"827","article-title":"The major pathway of imipramine metabolism is catalyzed by cytochromes P\u2010450 1A2 and P\u2010450 3A4 in human liver","volume":"43","author":"Lemoine A","year":"1993","journal-title":"Mol Pharmac"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199106060-00006"},{"key":"e_1_2_1_10_2","first-page":"170","article-title":"Possible interaction entre th\u00e9ophylline et fluvoxamine","volume":"46","author":"Diot P","year":"1991","journal-title":"Therapie"},{"key":"e_1_2_1_11_2","unstructured":"ThomsonAH McGovernEM BennieP CaldwellG SmithM.Interaction between fluvoxamine and theophylline.Pharmac J1st August 1992:137."},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-197803040-00002"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1983.tb01475.x"},{"key":"e_1_2_1_14_2","first-page":"31","article-title":"Characterisation of human liver cytochromes P\u2010450 involved in theophylline metabolism","volume":"20","author":"Sarkar MA","year":"1992","journal-title":"Drug Metab Disp"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.193"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1976195part1546"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1986.tb05239.x"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(88)90423-6"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(83)90026-4"},{"key":"e_1_2_1_20_2","first-page":"265","article-title":"Protein measurement with the folin phenol reagent","volume":"193","author":"Lowry OH","year":"1951","journal-title":"J clin Chem"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(91)90258-7"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(76)90527-3"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1992.tb05650.x"},{"key":"e_1_2_1_24_2","first-page":"233P","article-title":"Potent in vitro inhibition of human CYP1A2 by pharmacologically diverse agents","volume":"33","author":"Murray BP","year":"1992","journal-title":"Br J clin Pharmac"},{"key":"e_1_2_1_25_2","first-page":"237","article-title":"Biotransformation of caffeine, paraxanthine, theophylline and theobromine by polycyclic aromatic hydrocarbon\u2010inducible cytochrome(s) P\u2010450 in human liver microsomes","volume":"15","author":"Campbell ME","year":"1987","journal-title":"Drug Metab Disp"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.3109\/10408449409021606"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(88)90070-6"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00457a031"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1021\/tx00018a012"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1989.tb03516.x"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9861(91)90602-F"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0960-0760(93)90152-M"},{"key":"e_1_2_1_33_2","first-page":"1","article-title":"Characteristics of a microsomal cytochrome P\u2010448\u2010mediated reaction: Ethoxyresorufin O\u2010deethylation","volume":"5","author":"Burke MD","year":"1977","journal-title":"Drug Metab Disp"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(78)90245-2"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4347(94)00265-7"},{"key":"e_1_2_1_36_2","doi-asserted-by":"crossref","first-page":"11937","DOI":"10.1016\/S0021-9258(17)44323-7","article-title":"Regioselectivity and stereoselectivity of androgen hydroxylations catalyzed by cytochrome P\u2010450 isozymes purified from phenobarbital\u2010induced rat liver","volume":"258","author":"Waxman DJ","year":"1983","journal-title":"J biol Chem"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1006\/abio.1994.1446"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.116.3013.329"},{"key":"e_1_2_1_39_2","unstructured":"HolfordN.MK MODEL version 4 Biosoft Cambridge UK 1990."},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1042\/bj0550170"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199408000-00006"},{"key":"e_1_2_1_42_2","unstructured":"BertilssonL CarrilloJA DahlM\u2010L et al.Clozapine disposition covaries with the CYP1A2 activity determined by the caffeine test.Br J clin Pharmac submitted."},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199408000-00011"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00442557"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1021\/tx00020a008"},{"key":"e_1_2_1_46_2","first-page":"1357","article-title":"The induction and competitive inhibition of a high affinity microsomal nitrosodimethylamine demethylase by alcohol","volume":"12","author":"Peng R","year":"1982","journal-title":"Carcinogenesis"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00314987"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1984.118"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198632040-00002"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199206000-00004"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199306000-00011"},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1990.tb03686.x"},{"key":"e_1_2_1_53_2","first-page":"89","article-title":"CYP1A2\u2010catalyzed conversion of dietary heterocyclic amines to their proximate carcinogens is their major route of metabolism in humans","volume":"54","author":"Boobis AR","year":"1994","journal-title":"Cancer Res"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2125.1995.tb04422.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2125.1995.tb04422.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T23:33:12Z","timestamp":1698276792000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2125.1995.tb04422.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,2]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1995,2]]}},"alternative-id":["10.1111\/j.1365-2125.1995.tb04422.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2125.1995.tb04422.x","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,2]]}}}